On this page
Campomelic dysplasia
This rare disorder profoundly affects bone and cartilage formation, leading to distinctive bowing of the long bones and various other skeletal issues. It can also influence sex development, often affecting individuals from birth.
Available at Jeen Health
Clinical tests that include this
Overview
Campomelic dysplasia is a rare and severe genetic condition that primarily affects the development of bone and cartilage throughout the body. The term 'campomelic' comes from the Greek words for 'bent limb', referring to the characteristic bowing of the long bones, particularly in the legs [PMID:33008139]. Beyond skeletal features, this condition can also impact the development of other organ systems. While often identified at birth, the severity and specific features can vary among affected individuals.
Symptoms & clinical features
Individuals with Campomelic dysplasia typically present with a range of distinctive clinical features. The most characteristic is the bowing and angulation of the long bones, especially the tibiae (shin bones) and femurs (thigh bones) [PMID:20301321]. Other common skeletal findings include an unusually small chest, 11 pairs of ribs instead of the usual 12, hip dislocation, and clubfeet. Facial features may include a small chin and a broad nasal bridge. Respiratory problems are frequently observed due to the small, underdeveloped chest cavity, making breathing difficult for affected infants. About two-thirds of individuals with Campomelic dysplasia who are genetically male (XY chromosomes) develop female or ambiguous external genitalia, a phenomenon known as sex reversal [PMID:20301321].
Video: Genetics 101
Affected organs
The primary organs and systems affected in Campomelic dysplasia are the skeletal system, including bones, cartilage, and ribs. The small, bell-shaped chest can impact lung development and function, leading to breathing difficulties. Additionally, reproductive organs can be affected, particularly in individuals with XY chromosomes, leading to differences in sex development.
Risks & severity
Campomelic dysplasia is generally considered a severe condition. The respiratory complications due to the underdeveloped chest wall and associated tracheal malacia (softening of the windpipe) are a significant concern and can be life-threatening in infancy [PMID:20301321]. Other potential complications include an increased risk of hydrocephalus (fluid on the brain), kidney abnormalities, and heart defects. The exact prevalence of Campomelic dysplasia is not well established, but it is considered rare. The severity of the skeletal changes and other associated features can vary, though most cases present with significant health challenges from birth.
Genetic causes
Campomelic dysplasia is caused by pathogenic variants in the SOX9 gene. The SOX9 gene holds instructions for making a protein called SOX9, which acts as a transcription factor. This protein plays a crucial role in regulating other genes during development, particularly in forming bone and cartilage and in the development of male sex characteristics. When SOX9 is not functioning correctly due to a pathogenic variant, it disrupts these vital developmental processes. Most cases arise from a new, spontaneous variant in the SOX9 gene, meaning it is not inherited from either parent [PMID:20301321]. However, in some instances, it can be inherited.
- SOX9 SRY-box transcription factor 9The SOX9 gene provides instructions for a transcription factor protein essential for embryonic development, particularly in skeletal formation and sex determination.
Inheritance pattern
Campomelic dysplasia follows an autosomal dominant inheritance pattern. This means that a person only needs one altered copy of the SOX9 gene in each cell to be affected by the condition. In most cases, the genetic variant occurs spontaneously and is not inherited from a parent; this is known as a de novo variant. However, in some situations, a mildly affected parent may pass on the variant, or a parent may carry the variant in some of their cells (gonadal mosaicism) without showing symptoms themselves, which carries a small risk for recurrence in future children [PMID:20301321]. For affected individuals, there is a 50% chance of passing the condition to each of their children.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of Campomelic dysplasia is usually suspected based on characteristic skeletal features observed during prenatal ultrasound scans or shortly after birth. Genetic testing for variants in the SOX9 gene confirms the diagnosis. Referral for genetic testing in the UK is typically initiated by a paediatrician or clinical geneticist through the NHS Genomic Medicine Service. The 'Severe skeletal dysplasia' R-code (R169) on the NHS National Genomic Test Directory covers testing for conditions like Campomelic dysplasia, facilitating access to genomic sequencing for diagnosis.
Management & lifestyle
Management for Campomelic dysplasia is supportive and multidisciplinary, focusing on addressing the specific symptoms and complications an individual experiences. Given the rarity and complexity, care is typically coordinated through specialist paediatric centres within the NHS. Respiratory support is often critical in infancy due to the small chest and airway issues. Orthopaedic interventions may be considered for skeletal abnormalities, though severe bowing of long bones can be challenging to treat. Regular monitoring for potential complications such as hydrocephalus or kidney problems is also part of standard care. Genetic counselling is an essential part of the management pathway, providing information about the condition, its inheritance, and implications for family planning.
UK care pathway
In the UK, individuals suspected of having Campomelic dysplasia are typically referred to a clinical geneticist or specialist paediatric service. These services are part of the NHS Genomic Medicine Service (GMS) pathways. Genetic testing, often guided by the NHS National Genomic Test Directory using relevant R-codes like 'Severe skeletal dysplasia' (R169), helps confirm the diagnosis. A genetic counsellor will provide detailed information and support, explaining the condition, its inheritance, and implications for the family.
Frequently asked questions
Is Campomelic dysplasia always inherited from parents?
No, in most cases, Campomelic dysplasia results from a new genetic variant in the affected individual that was not present in either parent. This is known as a de novo variant. However, in a small number of cases, it can be inherited.
Can Campomelic dysplasia be detected before birth?
Yes, characteristic skeletal features such as bowed long bones and other abnormalities can often be detected during routine prenatal ultrasound scans. If suspected, further investigations, including genetic testing, may be offered.
What is sex reversal in Campomelic dysplasia?
Sex reversal in Campomelic dysplasia refers to the situation where an individual with XY chromosomes (genetically male) develops female or ambiguous external genitalia. This occurs in about two-thirds of affected XY individuals due to the SOX9 gene's role in male sex development.
What is the life expectancy for individuals with Campomelic dysplasia?
Campomelic dysplasia is a severe condition, and sadly, many affected infants do not survive beyond the first year of life primarily due to severe respiratory issues and airway problems. Survival past infancy is possible, though it often requires intensive medical support.
Where can I find support if my child has Campomelic dysplasia?
If your child has Campomelic dysplasia, your clinical genetics team and paediatricians are key resources. They can provide specific medical advice and direct you to support organisations. The Skeletal Dysplasia Group of AWI (Achieving a Better Life) in the UK may also offer valuable information and connections to other families.
References
- Adam MP, Bick S, Mirzaa GM. Campomelic Dysplasia. 1993. PMID: 20301724
- Feingold KR, Adler RA, Ahmed SF. Osteogenesis Imperfecta. 2000. PMID: 25905334
- Haseeb A, Kc R, Angelozzi M. SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation. Proceedings of the National Academy of Sciences of the United States of America. 2021. PMID: 33597301
- Goyal JP, Gupta A, Shah VB. Campomelic dysplasia. Indian journal of human genetics. 2011. PMID: 22346005
- Gimovsky M, Rosa E, Tolbert T. Campomelic dysplasia: case report and review. Journal of perinatology : official journal of the California Perinatal Association. 2008. PMID: 18165831
- Macpherson RI, Skinner SA, Donnenfeld AE. Acampomelic campomelic dysplasia. Pediatric radiology. 1989. PMID: 2602025
- Jain V, Sen B. Campomelic dysplasia. Journal of pediatric orthopedics. Part B. 2014. PMID: 24800790
- Wang L, Liu Z, Zhao S. Variants in the SOX9 transactivation middle domain induce axial skeleton dysplasia and scoliosis. Proceedings of the National Academy of Sciences of the United States of America. 2025. PMID: 39854231